JPS61197521A - ヘパリン製剤 - Google Patents

ヘパリン製剤

Info

Publication number
JPS61197521A
JPS61197521A JP61001227A JP122786A JPS61197521A JP S61197521 A JPS61197521 A JP S61197521A JP 61001227 A JP61001227 A JP 61001227A JP 122786 A JP122786 A JP 122786A JP S61197521 A JPS61197521 A JP S61197521A
Authority
JP
Japan
Prior art keywords
heparin
solution
salt
oxalate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61001227A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6355492B2 (mo
Inventor
ジヤン・グライ
ジヤン・シヨアイ
ジヤン・ピエール・デユクロ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Publication of JPS61197521A publication Critical patent/JPS61197521A/ja
Publication of JPS6355492B2 publication Critical patent/JPS6355492B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP61001227A 1977-08-08 1986-01-07 ヘパリン製剤 Granted JPS61197521A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB33170/77A GB1602439A (en) 1977-08-08 1977-08-08 Purified heparin
GB33170/77 1977-08-08
GB52047/77 1977-12-14

Publications (2)

Publication Number Publication Date
JPS61197521A true JPS61197521A (ja) 1986-09-01
JPS6355492B2 JPS6355492B2 (mo) 1988-11-02

Family

ID=10349469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61001227A Granted JPS61197521A (ja) 1977-08-08 1986-01-07 ヘパリン製剤

Country Status (3)

Country Link
JP (1) JPS61197521A (mo)
BE (1) BE869609A (mo)
GB (1) GB1602439A (mo)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016206204A (ja) * 2010-09-14 2016-12-08 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227797A (ja) * 1988-07-15 1990-01-30 Matsushita Electric Ind Co Ltd シールドケース

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016206204A (ja) * 2010-09-14 2016-12-08 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法
JP2019065306A (ja) * 2010-09-14 2019-04-25 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法

Also Published As

Publication number Publication date
BE869609A (fr) 1979-02-08
JPS6355492B2 (mo) 1988-11-02
GB1602439A (en) 1981-11-11

Similar Documents

Publication Publication Date Title
DE3885374T2 (de) Stabile wässerige Thrombinlösung.
US3868358A (en) Protamine-insulin product
CA1126652A (en) Antithrombin preparation and process for the production thereof
AU623232B2 (en) Novel compositions containing hyaluronic acid associates and a process for preparing same
US4652555A (en) Heparin compositions freed of mineral salts, particularly oxalates, and process for obtaining same
DE69012154T2 (de) Heparinderivate und Verfahren zu ihrer Herstellung.
JPS5874617A (ja) 人由来血液凝固第７因子含有水溶液の加熱処理方法
US3933996A (en) Composition comprising radioactive labeled-fibrinogen and albumin
DE2827027B2 (de) Gefriergetrocknetes natives T -globulin-Präparat zur intravenösen Verabreichung
NL8303657A (nl) Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
JPH03243601A (ja) 血液凝固の制御能をもつムコ多糖組成物およびその製造方法
DE2433209C3 (de) hitzestabilen Plasmaproteinpraparates
CN105324398B (zh) 用于生产化学修饰的肝素的新方法
US4185093A (en) Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
DE2459915B2 (de) Aktive Verbindung des Plasminogen-Typs, Verfahren zu ihrer Reinigung und ihre Verwendung
EP0123375B1 (en) Gamma-globulin preparation for intravenous administration
DE1442134C3 (de) In vivo antikoagulierend wirkendes und defibrinierendes Enzym
DE10246125A1 (de) Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
JPS6355492B2 (mo)
EP0127025B1 (de) Verfahren zur Herstellung eines Antihämophiliefaktor-Konzentrats
US1000214A (en) Process of preparing extractive compounds of the suprarenal gland.
GB2027728A (en) Physiologically Acceptable Heparin
DE69001309T2 (de) Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.
DE2409650C3 (de) Verwendung wäßriger Lösung von menschlichem Serum-Haptoglobin bei der Bekämpfung von hämolytischen Nierenstörungen
DE1942900C3 (de) Verfahren zur Abtrennung von L-Asparaginase aus Bakterienkulturen, danach hergestellte L-Asparaginase und diese enthaltendes therapeutisches Mittel